Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T07:43:40.024Z Has data issue: false hasContentIssue false

Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation*

Published online by Cambridge University Press:  09 July 2009

Max Birchwood
Affiliation:
Department of Clinical Psychology and Academic Unit, All Saints Hospital, Birmingham
Jo Smith*
Affiliation:
Department of Clinical Psychology and Academic Unit, All Saints Hospital, Birmingham
Fiona Macmillan
Affiliation:
Department of Clinical Psychology and Academic Unit, All Saints Hospital, Birmingham
Bridget Hogg
Affiliation:
Department of Clinical Psychology and Academic Unit, All Saints Hospital, Birmingham
Rekha Prasad
Affiliation:
Department of Clinical Psychology and Academic Unit, All Saints Hospital, Birmingham
Cathy Harvey
Affiliation:
Department of Clinical Psychology and Academic Unit, All Saints Hospital, Birmingham
Sandy Bering
Affiliation:
Department of Clinical Psychology and Academic Unit, All Saints Hospital, Birmingham
*
1Address for correspondence: Ms J. Smith, Department of Clinical Psychology and Academic Unit, All Saints Hospital, Lodge Road, Winson Green, Birmingham B18 5SD.

Synopsis

Recognition of prodromal symptoms of schizophrenia offers the potential of early intervention to avert relapse and re-hospitalization (Carpenter & Heinrichs, 1983). The present study investigated how a strategy to detect prodromal signs might be effectively applied in the clinical setting. A standard monitoring system was developed involving completion of a new early signs scale (ESS) measuring changes in key symptoms phenomenologically (self-report) and behaviourally (observer report). The ESS was subject to rigorous psychometric evaluation and tested in a prospective pilot investigation. The ESS reliably identified early signs and predicted relapse with an overall accuracy of 79%. Several different patterns of relapse were identified. Observer reports compensated for loss of insight in some patients. In two cases where early signs indices were detected, prompt increases in medication appeared to arrest relapse and avert readmission. The ESS offers itself as a reliable, valid and administratively feasible measure and demonstrates considerable potential as a cost-effective procedure for secondary prevention.

Type
Original Articles
Copyright
Copyright © Cambridge University Press 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

It should be noted that an equal contribution to the work described in this paper was made by the first three authors.

References

Baldessarini, R., & David, J. (1980). What is the best maintenance dose of neuroleptic in schizophrenia? Psychiatric Research 3, 115122.CrossRefGoogle ScholarPubMed
Carpenter, W. & Heinrichs, D. (1983). Early intervention, time limited targetted pharmacotherapy for schizophrenia. Schizophrenia Bulletin 9, 533542.CrossRefGoogle ScholarPubMed
Chapman, J. (1966). The early symptoms of schizophrenia. British Journal of Psychiatry 112, 225251.CrossRefGoogle ScholarPubMed
Dencker, S., Malm, L. & Hepp, M. (1986). Schizophrenic relapse after drug withdrawal is predictable. Acta Psychiatrica Scandinavica 75, 181185.CrossRefGoogle Scholar
Derogatis, L. & Melisaratos, N. (1983). The Brief Symptom Inventory: an introductory report. Psychological Medicine 13, 595605.CrossRefGoogle ScholarPubMed
Doherty, J., Van Kammen, D., Siris, S. & Marder, S. (1978). Stages of onset of schizophrenic psychosis. American Journal of Psychiatry 135, 420426.Google Scholar
Donlon, P. & Blacker, K. (1973). Stages of schizophrenic decompensation and reintegralion. Journal of Nervous and Mental Diseases 157, 200209.CrossRefGoogle Scholar
Guttman, L. (1945). A basis for analysing test-retest reliability Psychometrika 10, 255282.CrossRefGoogle Scholar
Heinrichs, D., Cohen, B. & Carpenter, W. (1985). Early insight and the management of schizophrenic decompensation. Journal of Nervous and Mental Diseases 173, 133138.CrossRefGoogle ScholarPubMed
Herz, M. & Melville, C. (1980). Relapse in schizophrenia. American Journal of Psychiatry 137, 801805.Google ScholarPubMed
Herz, M., Szymanski, H. & Simon, J. (1982). Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication. American Journal of Psychiatry 139, 918922.Google ScholarPubMed
Jolly, A., Hirsch, F., Manchanda, R. & McRink, A. (1989). Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients. British Medical Journal (in the press).Google Scholar
Kane, J., Rifkin, A., Woerner, M., Reardon, G., Sarantakos, S., Schiebel, D. & Ramos-Lorenzi, J (1983). Low dose neuroleptic treatment of outpatient schizophrenics: preliminary results for relapse rales. Archives of General Psychiatry 40, 893896.CrossRefGoogle Scholar
Krawiecka, M., Goldberg, D. & Vaughan, M. (1977). Standardised psychiatric assessment scale for chronic psychotic patients. Acta Psychiatrica Scandinavica 36, 2531.Google Scholar
Smith, J. & Birchwood, M. (1987). Specific and non-specific effects of educational intervention with families living with a schizophrenic relative. British Journal of Psychiatry 150, 645652.CrossRefGoogle ScholarPubMed
Wing, J., Cooper, J. & Sartorius, N. (1974). The Measurement and Classification of Psychiatric Symptoms- an Instruction Manual for the PSE and Calego Systems. Cambridge University Press: Cambridge.Google Scholar
World Health Organization (1979). Schizophrenia: An International Follow- Up Study. Wiley: London.Google Scholar